Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
577.45
-8.50 (-1.45%)
Jun 16, 2025, 3:29 PM IST
Lincoln Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Lincoln Pharmaceuticals had annual revenue of 6.23B INR with 7.35% growth. Lincoln Pharmaceuticals had revenue of 1.68B in the quarter ending March 31, 2025, with 18.03% growth.
Revenue
6.23B
Revenue Growth
+7.35%
P/S Ratio
1.88
Revenue / Employee
3.69M
Employees
1,687
Market Cap
11.73B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 6.23B | 426.81M | 7.35% |
Mar 31, 2024 | 5.81B | 702.41M | 13.76% |
Mar 31, 2023 | 5.10B | 381.86M | 8.09% |
Mar 31, 2022 | 4.72B | 479.38M | 11.30% |
Mar 31, 2021 | 4.24B | 376.95M | 9.75% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |